A serum hepcidin test measures the blood concentration of hepcidin, a small hormone produced by the liver that acts as the body’s master switch for iron regulation. The test matters because standard iron markers like ferritin and transferrin saturation can be misleading in the presence of inflammation, infection, or chronic disease, while hepcidin levels reveal what is actually happening to iron traffic in your body. Though not yet a routine part of standard blood panels in most hospitals, the test is increasingly used by specialists to sort out difficult anemia cases, guide iron therapy decisions, and monitor conditions where iron balance has gone off the rails.
What Hepcidin Actually Does
Hepcidin is a peptide hormone, just 25 amino acids long, that the liver releases into the bloodstream. Its single job is controlling how much iron gets into circulation. It does this by binding to ferroportin, the only known protein that exports iron out of cells and into the blood. When hepcidin locks onto ferroportin, the transporter gets pulled inside the cell and destroyed.1PubMed Central. Hepcidin targets ferroportin for degradation in hepatocytes The result: iron stays trapped inside intestinal cells (so you absorb less from food), inside macrophages (so recycled iron from old red blood cells stays locked up), and inside liver storage cells. Circulating iron drops.
Two main signals tell the liver to ramp up hepcidin production. The first is iron itself: when the body senses that iron stores are adequate or high, hepcidin rises to slam the brakes on further absorption.2PubMed Central. The role of hepcidin in iron metabolism The second is inflammation. The inflammatory molecule interleukin-6 (IL-6) directly switches on hepcidin production in the liver through a specific signaling pathway.3PubMed Central. Interleukin-6 induces hepcidin expression through STAT3 This is why people with chronic infections, autoimmune diseases, or cancer often develop anemia even when their total body iron is not low: inflammation drives hepcidin up, and hepcidin locks iron away where the bone marrow cannot use it to make red blood cells.
Conversely, when iron stores fall or the bone marrow desperately needs iron to churn out red blood cells, hepcidin drops. Low hepcidin opens the gates: more iron flows in from the gut and more gets released from storage. This push-pull system is elegant, but it also means that diseases affecting either signal (iron sensing or inflammation) can throw the whole balance off in ways that traditional blood tests struggle to capture.
Sorting Out the Type of Anemia
The single most compelling reason clinicians order a hepcidin test today is to distinguish between iron deficiency anemia (IDA) and anemia of chronic disease (ACD). These two conditions can look frustratingly similar on a standard lab panel. Ferritin, the go-to marker for iron stores, rises during inflammation regardless of how much iron you actually have. So a person with rheumatoid arthritis or inflammatory bowel disease might show a “normal” ferritin level while actually being iron-starved at the tissue level.
Hepcidin cuts through this ambiguity. In true iron deficiency, hepcidin is suppressed because the body is trying to let in as much iron as possible. In anemia of chronic disease, hepcidin is high because inflammation is driving it up. A study in children found that average hepcidin in pure ACD was roughly 144 ng/mL, compared with about 6 ng/mL in IDA and 25 ng/mL in healthy controls.4PubMed Central. Hepcidin and iron parameters in children with anemia of chronic disease and iron deficiency anemia That is a massive gap, and it makes diagnostic decisions far more clear-cut than trying to interpret a borderline ferritin in someone with active inflammation.
Research in patients with hidradenitis suppurativa confirmed the same pattern in adults, showing that hepcidin accurately separated IDA from ACD and also identified a mixed category where both conditions overlapped. In that study, cutoff values of about 9 ng/mL and 53 ng/mL helped distinguish the groups.5Journal of the American Academy of Dermatology. Hepcidin levels can distinguish anemia of chronic disease from iron deficiency anemia in a cross-sectional study of patients with hidradenitis suppurativa That middle zone, where hepcidin is neither very low nor very high, often signals that someone has both problems at once: genuine iron deficiency layered on top of chronic-disease inflammation. Recognizing that overlap matters because those patients may benefit from intravenous iron, whereas someone with pure ACD typically will not.
Predicting Whether Oral Iron Will Work
If you have been handed a bottle of iron tablets and told to take them for a few months, a hepcidin test could save you weeks of waiting and side effects. A study in patients with IDA found that those who failed to respond to oral iron had screening hepcidin levels averaging about 38 ng/mL, compared with roughly 11 ng/mL in responders. A cutoff above 20 ng/mL had strong specificity for predicting nonresponse, and hepcidin outperformed both transferrin saturation and ferritin for this purpose.6PubMed. Hepcidin levels predict nonresponsiveness to oral iron therapy in patients with iron deficiency anemia
The logic is straightforward. If hepcidin is elevated, ferroportin is being destroyed, and the iron you swallow gets trapped in gut cells and excreted when those cells are shed. You are essentially flushing iron pills down the drain. These patients often respond well to intravenous iron, which bypasses the gut entirely. In the same study, about two-thirds of oral-iron nonresponders later responded to intravenous iron. Knowing this upfront could spare people months of constipation, nausea, and frustration from ineffective tablets.
Hepcidin in Hereditary Iron Disorders
At the genetic extremes, hepcidin testing helps make sense of hereditary iron-loading and iron-wasting conditions. In hereditary hemochromatosis, the most common genetic iron overload disorder, the core problem is that hepcidin production is inappropriately low. Without enough hepcidin to apply the brakes, iron pours in from every meal and accumulates in the liver, heart, and pancreas over years.7PubMed. Hepcidin and disorders of iron metabolism A low hepcidin level relative to high iron stores is a red flag that fits the hemochromatosis picture and can help clinicians confirm the diagnosis alongside genetic testing.
On the opposite end sits a rare condition called iron-refractory iron deficiency anemia, or IRIDA. People with IRIDA have genetic mutations that prevent their bodies from properly shutting off hepcidin production, so hepcidin stays high even when iron stores are rock-bottom. These patients absorb almost no iron from food or oral supplements, and the iron recycled from old red blood cells stays locked in macrophages.8Gastroenterology. Hepcidin: The Hemochromatosis Hormone – Section: The Hepcidin Iron-Sensing Machinery and Hemochromatosis They present a baffling clinical picture: severe iron deficiency that refuses to budge with standard treatment. A hepcidin test showing paradoxically high levels in the face of clear iron deficiency is one of the strongest clues pointing toward IRIDA.
Kidney Disease and the Anemia Puzzle
Chronic kidney disease (CKD) creates a particularly tangled iron problem. The kidneys normally clear some hepcidin from the blood, so when kidney function declines, hepcidin accumulates. At the same time, CKD patients frequently have chronic low-grade inflammation, which further pushes hepcidin up. The result is iron sequestration: the body has iron, but it is locked away where the bone marrow cannot reach it. Combined with reduced production of erythropoietin (the hormone that stimulates red blood cell production), this hepcidin-mediated iron restriction is a major contributor to CKD-related anemia.9PubMed Central. Iron Balance and the Role of Hepcidin in Chronic Kidney Disease
In patients on hemodialysis, hepcidin levels tend to reflect systemic iron load, and both dialysis itself and erythropoietin therapy appear to lower circulating hepcidin.10PubMed. Serum hepcidin concentration in chronic haemodialysis patients: associations and effects of dialysis, iron and erythropoietin therapy Tracking hepcidin in these patients could help nephrologists decide when intravenous iron is likely to be effective and when it would just pile more iron into storage without benefiting red blood cell production. Standard markers like ferritin are notoriously unreliable in dialysis patients, so hepcidin fills a real clinical gap here.
Pregnancy and Maternal Iron Transfer
During pregnancy, the body naturally suppresses hepcidin to ensure that more iron reaches both the mother’s expanding blood volume and the developing fetus. Pregnant women with very low or undetectable hepcidin transfer a greater share of ingested iron to their fetus compared with women who have detectable hepcidin, suggesting that maternal hepcidin partly determines how much iron the baby receives.11PubMed Central. Hepcidin and Iron Homeostasis during Pregnancy
This becomes especially relevant in obese pregnant women, who tend to have higher hepcidin levels at the end of pregnancy compared with normal-weight women.12international journal of obesity. The impact of maternal obesity on iron status, placental transferrin receptor expression and hepcidin expression in human pregnancy Higher maternal hepcidin may impair iron transfer to the fetus, potentially contributing to the lower iron stores seen in newborns of obese mothers. While hepcidin testing in pregnancy is still largely a research tool, it could eventually help identify which mothers need more aggressive iron supplementation strategies.
Athletes and Exercise-Induced Iron Loss
Endurance athletes are famously prone to iron deficiency, and hepcidin appears to be a key part of the explanation. A single bout of moderate-to-high-intensity running or cycling triggers a spike in hepcidin that peaks roughly three hours after exercise ends.13PubMed Central. Effects of an Acute Exercise Bout on Serum Hepcidin Levels The mechanism involves IL-6 released from working muscles: the same inflammatory signal that drives hepcidin up in chronic disease operates in a short burst after a hard workout.
A study in trained runners found that a prolonged bout of running increased plasma hepcidin by about 50% and reduced fractional iron absorption by roughly a third compared with rest.14PubMed. A Prolonged Bout of Running Increases Hepcidin and Decreases Dietary Iron Absorption in Trained Female and Male Runners In practical terms, this means that the iron-rich meal you eat right after a long run is poorly absorbed because your hepcidin is peaking. Some sports nutritionists now advise athletes to time their iron-rich meals or supplements away from the post-exercise window, eating them in the early morning or well before training, when hepcidin is at its lowest.
For athletes with persistent low ferritin despite adequate dietary iron, a hepcidin test can help determine whether exercise-driven hepcidin surges or an underlying condition are to blame. Athletes with very low pre-exercise ferritin tend to have a blunted hepcidin response to exercise, which is the body’s protective attempt to keep iron gates open. When that response is not blunted, it suggests something else is pushing hepcidin up.
Practical Considerations for the Test Itself
One reason the hepcidin test has not yet become a standard order on every lab requisition is that the assay landscape is still maturing. Two main types of measurement exist: immunoassays (ELISA-based tests) and mass spectrometry methods. These correlate reasonably well with each other, but they do not always produce the same absolute numbers. In one comparison of critically ill patients, ELISA and mass spectrometry showed good agreement in classifying patients into the same categories, but the raw concentrations differed, meaning cutoff values must be calibrated to the specific assay used.15Bioanalysis. Analytical comparison of ELISA and mass spectrometry for quantification of serum hepcidin in critically ill patients Mass spectrometry can also distinguish between different hepcidin forms (hepcidin-25, the active form, versus shorter inactive fragments), which can matter in conditions like kidney disease where inactive isoforms accumulate.16Clinical Chemistry. Immunochemical and Mass-Spectrometry–Based Serum Hepcidin Assays for Iron Metabolism Disorders
Timing also matters. Hepcidin follows a natural daily rhythm, with concentrations lowest in the early morning and rising steadily through the afternoon before declining in the evening. This pattern persists regardless of food intake, driven by an innate diurnal rhythm rather than dietary iron.17PubMed. Circulating human hepcidin-25 concentrations display a diurnal rhythm, increase with prolonged fasting, and are reduced by growth hormone administration18PubMed. Diurnal rhythm rather than dietary iron mediates daily hepcidin variations For the most consistent and interpretable results, morning blood draws are preferable. A sample taken at 4 PM could read noticeably higher than one taken at 8 AM in the same person on the same day, which would obviously affect clinical interpretation.
There is also the matter of establishing universal reference ranges. A systematic review of hepcidin values in healthy young adults found significant variability between studies, driven partly by assay differences and partly by population characteristics.19PubMed Central. Hepcidin levels in healthy young adults: Findings from a systematic review and meta-analysis of reference intervals Without agreed-upon global reference ranges tied to a specific standardized assay, interpreting a hepcidin number in isolation requires knowing which lab ran the test and what method they used. This is a solvable problem, and international harmonization efforts are underway, but it is part of why the test remains somewhat specialist-facing for now.
Urinary Hepcidin as a Needle-Free Alternative
Because hepcidin is a small peptide filtered by the kidneys, it shows up in urine. Researchers have explored whether urinary hepcidin, adjusted for creatinine concentration, could serve as a noninvasive stand-in for the blood test. In female athletes, urinary hepcidin-to-creatinine ratio correlated strongly with serum hepcidin and showed similar diagnostic accuracy for identifying iron deficiency, with sensitivity and specificity values in the mid-70s to low-90s depending on the cutoff.20PubMed Central. Potential Usefulness of Urinary Hepcidin Measurement for Iron Deficiency Anemia in Female Athletes
In young women of reproductive age, urinary hepcidin showed strong discriminating power for evaluating iron status, with a diagnostic sensitivity above 80% and specificity above 83%.21PubMed Central. Role of Serum and Urinary Hepcidin in Young Females of Reproductive Age in North India Interestingly, one study in children under five found that urinary hepcidin actually outperformed serum hepcidin for diagnosing iron deficiency anemia in that specific age group.22Journal of Pediatric Hematology/Oncology. Serum and Urinary Hepcidin for Diagnosing Iron-deficiency Anemia in Under-5 Children The appeal is obvious: collecting urine from a toddler is far easier and less traumatic than drawing blood. These findings are still early-stage and need broader validation, but urinary hepcidin could eventually make iron screening practical in settings where blood draws are a barrier, such as sports teams doing routine monitoring or pediatric clinics in resource-limited areas.
Hepcidin’s Antimicrobial Side
Hepcidin’s role in locking iron away during infection is not a coincidence or a side effect. It is an ancient defense strategy. Many dangerous bacteria, including those that cause sepsis and wound infections, need free iron in the bloodstream to grow. By pulling iron out of circulation during an infection, hepcidin starves these invaders of a critical nutrient. Research in zebrafish has shown that hepcidin originally functioned as a direct antimicrobial peptide, capable of killing bacteria on contact. Over evolutionary time, it acquired its hormonal iron-regulating function on top of this bactericidal activity, giving vertebrates a two-pronged defense: it both poisons bacteria directly and denies them the iron they need.23Scientific Reports. Coordination of Bactericidal and Iron Regulatory Functions of Hepcidin in Innate Antimicrobial Immunity in a Zebrafish Model
This evolutionary backstory explains a clinical reality that puzzles many patients: why their doctor sometimes hesitates to give iron supplements during an active infection, even when lab work shows low iron. Driving iron levels up while a serious bacterial infection is raging can feed the very organisms the immune system is trying to kill. Hepcidin testing in the context of serious infection could eventually help clinicians decide when it is safe to replenish iron and when it is better to wait.
Hepcidin-Targeted Therapies on the Horizon
Beyond diagnostics, hepcidin is becoming a drug target. Pharmaceutical companies are developing hepcidin agonists, synthetic molecules that mimic hepcidin’s action, for conditions where the body produces too little of it. In hereditary hemochromatosis, for example, a hepcidin agonist could replace what the body fails to make, reducing iron absorption without the need for regular phlebotomy. The same approach could benefit patients with beta-thalassemia, where ineffective red blood cell production suppresses hepcidin and leads to dangerous iron overload even without transfusions. Preclinical work suggests these agonists could also protect against severe infections caused by iron-loving bacteria in patients with iron overload or chronic liver disease.24PubMed Central. Hepcidin agonists as therapeutic tools
On the flip side, researchers are exploring hepcidin antagonists and anti-hepcidin antibodies for conditions where hepcidin is too high, like anemia of chronic kidney disease or anemia of chronic inflammation. If you could lower hepcidin pharmacologically, you could unlock the iron trapped in macrophages and storage cells without needing intravenous iron infusions. These therapies are still largely in clinical trials, but they represent a fundamentally different approach to treating anemia: instead of forcing iron in from outside, you fix the regulatory signal that is keeping the body’s own iron supply locked away.
For the test itself, the trajectory seems clear. As assays become more standardized and reference ranges better defined, serum hepcidin will likely move from a specialist curiosity to a routine part of the anemia workup, sitting alongside ferritin and transferrin saturation on the lab order form. For anyone who has been told their iron numbers “don’t quite add up,” that day cannot come soon enough.